TABLE 1.
Receptor |
GABA EC50 [95% CI (n)] | GABA Efficacy ± S.D. |
IPTX/IGABAmax ± S.D. |
---|---|---|---|
µM | |||
α1β3γ2L | 59 [53–66 (n = 3)] | 0.88 ± 0.024 (n = 5) | <0.001 (n = 3) |
M2-15′ | |||
α1S270Iβ3γ2L | 2.3 [2.1–2.6 (n = 3)] | 0.78 ± 0.054 (n = 6) | 0.020 ± 0.0072 (n = 3) |
α1β3N265Mγ2L | 141 [128–156 (n = 3)] | 0.75 ± 0.024 (n = 4) | <0.001 (n = 3) |
α1β3γ2LS280W | 29 [24–35 (n = 4)] | 0.70 ± 0.053 (n = 3) | 0.015 ± 0.0043 (n = 3) |
M3-36′ | |||
α1A291Wβ3γ2L | 0.37 [0.27–0.52 (n = 3)] | 0.99 ± 0.036 (n = 6) | 0.10 ± 0.014 (n = 3) |
α1β3M286Wγ2L | 5.9 [4.5–7.7 (n = 4)] | 0.96 ± 0.032 (n = 5) | 0.061 ± 0.034 (n = 5) |
α1β3γ2LS301W | 43 [32–58 (n = 3)] | 0.84 ± 0.054 (n = 7) | 0.078 ± 0.0088 (n = 3) |
CI, confidence interval.